Search results: Sage Journals

Open accessResearch articleFirst published 2022

Post-authorisation safety study of burosumab use in paediatric,adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Maria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Open accessResearch articleFirst published 2026

Evaluating the patterns of use and safety of lenalidomide treatment in myelodysplastic syndromes: a European,observational multi-registry study

Iris Kim, Aidan Makwana, Victoria Ezenma [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published February, 2013

Pharmacovigilance and risk management in the EU

María Dolores Cabezas López

Pharmaceuticals Policy and Law

Restricted accessResearch articleFirst published November, 2011

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance: application to diabetes and vascular disease

Kevin V Blake, Camilla Smeraldi, Xavier Kurz [...]

The British Journal of Diabetes & Vascular Disease

Open accessResearch articleFirst published 2024

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Annemieke M. Boot, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published June, 2014

Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa® (testosterone patch)

Vicki Osborne, Deborah Layton, Saad AW Shakir

Post Reproductive Health

Open accessResearch articleFirst published 2023

Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review

Nokuthula L. Makhene, Hanlie Steyn, Martine Vorster [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published March, 2022

Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy – A prospective,observational study of 8056 treatments

Huw OB Davies, Mike Watkins, Richard Oliver [...]

Phlebology: The Journal of Venous Disease

Open accessResearch articleFirst published April, 2022

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain

Jose J. Garcia-Medina, Javier Benitez-del-Castillo, Iñaki Rodríguez-Agirretxe [...]

Journal of Ocular Pharmacology and Therapeutics

Open accessResearch articleFirst published 2025

Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases

Frank Andersohn, Pedro Such, Michael Jan [...]

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published 2022

Post-authorisation safety study of burosumab use in paediatric,adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Maria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Open accessResearch articleFirst published 2026

Evaluating the patterns of use and safety of lenalidomide treatment in myelodysplastic syndromes: a European,observational multi-registry study

Iris Kim, Aidan Makwana, Victoria Ezenma [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published February, 2013

Pharmacovigilance and risk management in the EU

María Dolores Cabezas López

Pharmaceuticals Policy and Law

Restricted accessResearch articleFirst published November, 2011

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance: application to diabetes and vascular disease

Kevin V Blake, Camilla Smeraldi, Xavier Kurz [...]

The British Journal of Diabetes & Vascular Disease

Open accessResearch articleFirst published 2024

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Annemieke M. Boot, Gema Ariceta, Signe Sparre Beck-Nielsen [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published June, 2014

Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa® (testosterone patch)

Vicki Osborne, Deborah Layton, Saad AW Shakir

Post Reproductive Health

Open accessResearch articleFirst published 2023

Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review

Nokuthula L. Makhene, Hanlie Steyn, Martine Vorster [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published March, 2022

Adverse neurological events after sodium tetradecyl sulfate foam sclerotherapy – A prospective,observational study of 8056 treatments

Huw OB Davies, Mike Watkins, Richard Oliver [...]

Phlebology: The Journal of Venous Disease

Open accessResearch articleFirst published April, 2022

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain

Jose J. Garcia-Medina, Javier Benitez-del-Castillo, Iñaki Rodríguez-Agirretxe [...]

Journal of Ocular Pharmacology and Therapeutics

Open accessResearch articleFirst published 2025

Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases

Frank Andersohn, Pedro Such, Michael Jan [...]

Therapeutic Advances in Psychopharmacology